IPO Roundup: American Integrity Insurance, Apimeds Pharmaceuticals and more
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 05 2025
0mins
Source: SeekingAlpha
U.S. IPO Market Overview: The U.S. IPO market is showing stability with the S&P 500 experiencing nine consecutive days of gains, while American Integrity Insurance Group plans to raise over $100M for expansion into new states amidst a competitive insurance landscape.
Upcoming IPOs and SPACs: Several companies are preparing for IPOs this week, including Apimeds Pharmaceuticals and Aspen Insurance Holdings, with various amounts being raised across different sectors, alongside multiple SPAC filings aiming for significant capital raises.
Analyst Views on IPOS
Wall Street analysts forecast IPOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 18.945
Low
Averages
High
Current: 18.945
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
